Trial Profile
Phase I trial of SPI-183 for treatment of pulmonary arterial hypertension (PAH)
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 31 Mar 2015
Price :
$35
*
At a glance
- Drugs SPI 183 (Primary)
- Indications Pulmonary arterial hypertension
- Focus Adverse reactions
- 31 Mar 2015 New trial record